Greenhitech Ven. (544163)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 71.65% shows strong top-line momentum.
• Latest quarter sales of ₹19 Cr are meaningful relative to the ₹68 Cr market cap, so margin recovery could drive earnings.
• If the latest quarter is annualised, the price-to-sales ratio is roughly 0.9x, which is not demanding on a sales basis.
• The stock is close to its 52-week high of ₹141.80, indicating active market interest in the growth story.

Concerns

• Profit growth is -78.43% and the latest quarterly net profit is ₹0 Cr, making the 96.54 P/E highly dangerous.
• ROCE is 0.00%, meaning the company is currently earning no return on capital.
• Piotroski F-Score of 3/9 signals weak financial health and poor operating fundamentals.
• Missing data on book value, debt/equity, and promoter holding prevents any credible margin-of-safety calculation.

AI Analysis

Let me start with the numbers that matter. Greenhitech Ven. trades at ₹137.50, near its 52-week high of ₹141.80, with a market cap of just ₹68 Cr. Yet the latest quarter shows sales of ₹19 Cr but net profit of ₹0 Cr. Sales grew 71.65%, but profit growth fell 78.43%. As Graham would say, if you pay 96.54 times earnings, you are not buying value; you are buying hope. With ROCE at 0.00%, the business is currently earning no return on the capital employed. The Piotroski score of 3/9 confirms weak financial health — this is not the profile of a high-quality compounder. High sales growth is meaningless to me unless it converts into profits. If I annualise the latest quarter, sales are roughly ₹76 Cr against a ₹68 Cr market cap, so the sales multiple is not absurd. But that assumes margins can recover. That is an assumption I am not willing to make without data on book value, debt/equity, and promoter holding. A zero dividend and zero profit means the retail investor is entirely dependent on someone else paying a higher price. That is speculation, not investment. At near the top of its range, there is no margin of safety. I would wait until the company demonstrates sustained margin expansion, positive ROCE, and consistent profit growth. This is a possible turnaround, not a proven one. For now, it stays on my watchlist, not in my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer